Davide Serrano

6.2k total citations
97 papers, 2.7k citations indexed

About

Davide Serrano is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Davide Serrano has authored 97 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 42 papers in Oncology and 28 papers in Cancer Research. Recurrent topics in Davide Serrano's work include Estrogen and related hormone effects (38 papers), Cancer Risks and Factors (24 papers) and Breast Cancer Treatment Studies (22 papers). Davide Serrano is often cited by papers focused on Estrogen and related hormone effects (38 papers), Cancer Risks and Factors (24 papers) and Breast Cancer Treatment Studies (22 papers). Davide Serrano collaborates with scholars based in Italy, United States and Norway. Davide Serrano's co-authors include Andrea DeCensi, Bernardo Bonanni, Aliana Guerrieri‐Gonzaga, Sara Gandini, Matteo Lazzeroni, Harriet Johansson, Massimiliano Cazzaniga, Patrizia Gnagnarella, Sara Raimondi and Giancarlo Pruneri and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Davide Serrano

89 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Davide Serrano Italy	31	955	919	700	602	545	97	2.7k
Tilman T. Rau Germany	33	1.0k 1.1×	1.1k 1.2×	462 0.7×	623 1.0×	567 1.0×	113	3.8k
Karen W. Makar United States	32	995 1.0×	1.4k 1.6×	382 0.5×	582 1.0×	601 1.1×	78	3.7k
Angela Hague United Kingdom	25	758 0.8×	1.4k 1.6×	380 0.5×	441 0.7×	458 0.8×	53	2.8k
William E. Friedrichs United States	27	724 0.8×	1.5k 1.7×	604 0.9×	470 0.8×	175 0.3×	46	3.0k
Qinglei Gao China	33	1.0k 1.1×	2.1k 2.2×	277 0.4×	756 1.3×	240 0.4×	171	3.7k
Kazuma Kiyotani Japan	37	2.1k 2.2×	1.2k 1.3×	640 0.9×	508 0.8×	190 0.3×	131	4.2k
Min Huang China	32	1.4k 1.5×	1.1k 1.2×	368 0.5×	425 0.7×	184 0.3×	96	3.6k
Xiangjun Gu United States	24	582 0.6×	1.3k 1.4×	1.1k 1.5×	425 0.7×	263 0.5×	45	3.5k
Jae Wha Kim South Korea	30	664 0.7×	1.8k 2.0×	222 0.3×	415 0.7×	407 0.7×	114	2.9k
Shuping Zhao China	28	599 0.6×	1.3k 1.5×	172 0.2×	454 0.8×	469 0.9×	68	2.9k

Countries citing papers authored by Davide Serrano

Since Specialization

Citations

This map shows the geographic impact of Davide Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Serrano more than expected).

Fields of papers citing papers by Davide Serrano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Serrano. The network helps show where Davide Serrano may publish in the future.

Co-authorship network of co-authors of Davide Serrano

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Serrano. A scholar is included among the top collaborators of Davide Serrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Serrano. Davide Serrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serrano, Davide, Cristina Zanzottera, Francesca Fava, et al.. (2025). Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies. Genes. 16(1). 82–82. 1 indexed citations

Carbone, Alessio, Martino Oliva, Matteo Puntoni, et al.. (2025). Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer. JNCI Journal of the National Cancer Institute.

Fava, Francesca, Monica Marabelli, Mariarosaria Calvello, et al.. (2025). MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?. Tumori Journal. 3887655698–3887655698. 1 indexed citations

Ruscica, Massimiliano, Chiara Macchi, Sara Gandini, et al.. (2024). Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers. 16(7). 1411–1411.

Serrano, Davide, Federica Bellerba, Harriet Johansson, et al.. (2023). Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial. Biomedicines. 11(6). 1766–1766. 3 indexed citations

Serrano, Davide, et al.. (2023). Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer. Healthcare. 11(16). 2360–2360. 4 indexed citations

Calvello, Mariarosaria, Monica Marabelli, Sara Gandini, et al.. (2023). Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience. Genes. 14(5). 1077–1077. 5 indexed citations

Serrano, Davide, Chiara Pozzi, Silvia Guglietta, et al.. (2021). Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and Adipokines. Nutrients. 13(2). 363–363. 15 indexed citations

Lazzeroni, Matteo, Andrea DeCensi, Aliana Guerrieri‐Gonzaga, et al.. (2020). Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast. Modern Pathology. 33(6). 1065–1077. 5 indexed citations

10.

Johansson, Harriet, Valentina Aristarco, Sara Gandini, et al.. (2019). Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The Pharmacogenomics Journal. 20(1). 19–26. 9 indexed citations

11.

Johansson, Harriet, Sara Gandini, Davide Serrano, et al.. (2016). A pooled analysis of CYP2D6 genotype in breast cancer prevention trials of low-dose tamoxifen. Breast Cancer Research and Treatment. 159(1). 97–108. 11 indexed citations

12.

DeCensi, Andrea, Matteo Puntoni, Aliana Guerrieri‐Gonzaga, et al.. (2015). Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial. Cancer Prevention Research. 8(10). 888–894. 27 indexed citations

13.

Serrano, Davide, Matteo Lazzeroni, & Bernardo Bonanni. (2014). Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches. Molecular Oncology. 9(5). 1008–1017. 25 indexed citations

14.

Gandini, Sara, Aliana Guerrieri‐Gonzaga, Giancarlo Pruneri, et al.. (2013). Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials. Annals of Oncology. 25(3). 618–623. 29 indexed citations

15.

Bonanni, Bernardo, Matteo Puntoni, Massimiliano Cazzaniga, et al.. (2012). Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial. Journal of Clinical Oncology. 30(21). 2593–2600. 195 indexed citations

16.

DeCensi, Andrea, Matteo Puntoni, Giancarlo Pruneri, et al.. (2011). Lapatinib Activity in Premalignant Lesions and HER-2–Positive Cancer of the Breast in a Randomized, Placebo-Controlled Presurgical Trial. Cancer Prevention Research. 4(8). 1181–1189. 48 indexed citations

17.

DeCensi, Andrea, Aliana Guerrieri‐Gonzaga, Sara Gandini, et al.. (2010). Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Annals of Oncology. 22(3). 582–587. 59 indexed citations

18.

Serrano, Davide, Matteo Lazzeroni, Carlo‐Federico Zambon, et al.. (2010). Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial. The Pharmacogenomics Journal. 11(2). 100–107. 52 indexed citations

19.

Lazzeroni, Matteo, Aliana Guerrieri‐Gonzaga, Davide Serrano, et al.. (2010). Budesonide versus placebo in high-risk population with screen-detected lung nodules: Rationale, design and methodology. Contemporary Clinical Trials. 31(6). 612–619. 8 indexed citations

20.

Johansson, Harriet, Sara Gandini, Bernardo Bonanni, et al.. (2007). Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Research and Treatment. 108(1). 57–67. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact